28 /100
MEDIUM RISK
Score updated Jul 14, 2026

UAMY — United States Antimony Corporation Dilution Risk Tracker

Track UAMY dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track UAMY — Get alerts when the score changes →

As of July 14, 2026, United States Antimony Corporation (UAMY) has a DilutionWatch DilutionScore of 28/100, rated MEDIUM dilution risk. United States Antimony Corporation has a market capitalization of $1.33B, 148.19M shares outstanding, 242 institutional holders tracked. Key dilution vectors include approximately 22 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
42
💰 Cash Runway
25
📊 Float Risk
12
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for UAMY.
🔔 Track UAMY — Get forecast alerts →

💹 Market Data

Market Cap$1.33B
Shares Outstanding148.19M
Float130.24M
Cash$7.84M
Debt$199.9K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 32.0% shares (2026Q1 vs prior)
242 institutional holders · 95.91M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 10.40M shares
#2 VAN ECK ASSOCIATES CORP 10.37M shares
#3 BlackRock, Inc. 9.88M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest34.20M
Days to Cover4.4
% of Float26.3%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Jan 31, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2023
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for UAMY Shareholders

United States Antimony Corporation (UAMY) has a DilutionScore of 28/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.

DilutionWatch's EDGAR monitoring for UAMY shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for UAMY in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for UAMY alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track UAMY Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking UAMY — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for UAMY
📊 UAMY FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 UAMY Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.